Latest News of BMRN
BioMarin Pharmaceutical Inc. (BMRN): Is This Biotech Stock A Good Buy?
By Yahoo! Finance |
3 weeks ago
The article discusses the top biotech stocks to invest in, focusing on BioMarin Pharmaceutical Inc. It highlights the growth potential of the biotechnology industry, market trends, stock analysis, and...
BioMarin Pharmaceutical Inc (BMRN): Are Hedge Funds Bullish on This Elliott Management-Approved Stock Now?
By Yahoo! Finance |
1 month ago
Elliott Management's top 10 stock picks include BioMarin Pharmaceutical Inc (BMRN). The hedge fund, led by billionaire Paul Singer, is known for successful investments in underperforming companies and...
Here's Why Parnassus Value Equity Fund Sold BioMarin Pharmaceutical (BMRN)
By Yahoo! Finance |
3 months ago
Parnassus Investments' "Parnassus Value Equity Fund" outperformed the Russell 1000 Value Index in Q1 2024. Key contributors were stock selections in IT and Communication sectors. BioMarin Pharmaceutic...
-
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Shares Could Be 41% Below Their Intrinsic Value Estimate
By Yahoo! Finance | 3 months agoThe fair value estimate for BioMarin Pharmaceutical is 32% higher than the analyst price target. Using a 2-stage DCF model, the intrinsic value is estimated at US$27 billion, indicating the stock is u...
-
Should You Hold BioMarin Pharmaceutical (BMRN) Despite Setback?
By Yahoo! Finance | 3 months agoScout Investments, Inc, under Carillon Tower Advisers, released the Q1 2024 investor letter for the "Carillon Scout Mid Cap Fund." The letter discusses market trends, highlights like BioMarin Pharmace...